Log in to save to my catalogue

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial Hypertensio...

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial Hypertensio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754003992

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial Hypertension

About this item

Full title

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial Hypertension

Publisher

New York, NY: American Thoracic Society

Journal title

American journal of respiratory and critical care medicine, 2010-09, Vol.182 (6), p.805-818

Language

English

Formats

Publication information

Publisher

New York, NY: American Thoracic Society

More information

Scope and Contents

Contents

Idiopathic pulmonary arterial hypertension (IPAH) is characterized by medial hypertrophy due to pulmonary artery smooth muscle cell (paSMC) hyperplasia. Inflammation is proposed to play a role in vessel remodeling associated with IPAH. IL-13 is emerging as a regulator of tissue remodeling; however, the contribution of the IL-13 system to IPAH has n...

Alternative Titles

Full title

Dysregulation of the IL-13 Receptor System: A Novel Pathomechanism in Pulmonary Arterial Hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_754003992

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754003992

Other Identifiers

ISSN

1073-449X

E-ISSN

1535-4970

DOI

10.1164/rccm.200909-1367oc

How to access this item